[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Investseekers [@investseekers](/creator/twitter/investseekers) on x 2655 followers Created: 2025-07-17 07:07:17 UTC $GMAB shares rose XXX% yesterday after positive news from partner $JNJ on Darzalex sales. And today, $NVS reported stronger-than-expected Q2 sales of Kesimpta at $1.08B vs. $1.06B expected. Genmab receives XX% royalties on Kesimpta. #stocks #investingtips XXXXX engagements  **Related Topics** [$gmabco](/topic/$gmabco) [$106b](/topic/$106b) [$108b](/topic/$108b) [$nvs](/topic/$nvs) [$jnj](/topic/$jnj) [stocks](/topic/stocks) [$gmab](/topic/$gmab) [johnson johnson](/topic/johnson-johnson) [Post Link](https://x.com/investseekers/status/1945742082158543322)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Investseekers @investseekers on x 2655 followers
Created: 2025-07-17 07:07:17 UTC
$GMAB shares rose XXX% yesterday after positive news from partner $JNJ on Darzalex sales. And today, $NVS reported stronger-than-expected Q2 sales of Kesimpta at $1.08B vs. $1.06B expected. Genmab receives XX% royalties on Kesimpta.
#stocks #investingtips
XXXXX engagements
Related Topics $gmabco $106b $108b $nvs $jnj stocks $gmab johnson johnson
/post/tweet::1945742082158543322